rAAVen to Present at #ASGCT2024 and Myrtelle Symposium

rAAVen Therapeutics is pleased to share the news on our participation in this year’s  #ASGCT2024, and the symposium held by Myrtelle, Inc., where we will be presenting the latest findings on AAVs targeting oligodendrocytes.